LINC01118 and neoplasm: Of pertinence, STAT6 has been described to act as a tumor suppressor in breast cancer69,70, providing a possible mechanism-of-action of LINC01119/SOCS5 in driving TNBC cell growth by curtailing STAT6 activation.